Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance
Roberto Campagna, Valentina Pozzi, Sara Giorgini, Doriana Morichetti, Gaia Goteri, Davide Sartini, Emma Nicol Serritelli, Monica Emanuelli
Topics & Concepts
Triple-negative breast cancerDownregulation and upregulationBreast cancerCancer researchEstrogen receptorCarcinogenesisCancerMedicineChemotherapyOncologyInternal medicineBiologyGeneBiochemistryParaoxonase enzyme and polymorphismsChemotherapy-induced cardiotoxicity and mitigationChemotherapy-induced organ toxicity mitigation